Aehr Test Systems
Price Action
Technical Summary
STAGE 2 UPTRENDAehr Test Systems is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 98), indicating clear outperformance against the broad market. Earnings contraction of 217% provides fundamental context to the price action. However, price is extended 66% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $85.28 | +13.42% | ABOVE |
| 50 SMA | $58.19 | +66.22% | ABOVE |
| 100 SMA | $42.17 | +129.40% | ABOVE |
| 150 SMA | $36.36 | +166.02% | ABOVE |
| 200 SMA | $33.17 | +191.63% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AEHR in an uptrend right now?
AEHR has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, AEHR is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is AEHR overbought or oversold?
AEHR's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is AEHR outperforming the market?
AEHR has a Relative Strength (RS) Rating of 98 out of 99. Yes, AEHR is a market leader, outperforming 98% of all stocks over the past 12 months.
Where is AEHR in its 52-week range?
AEHR is trading at $96.73, which is 94% of its 52-week high ($102.48) and 94% above its 52-week low ($8.02).
How volatile is AEHR?
AEHR has a Beta of 4.77 and 52-week volatility of 113%. It's more volatile than the S&P 500 - expect bigger swings.